BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 17082730)

  • 1. QT interval in patients with primary aldosteronism and low-renin essential hypertension.
    Maule S; Mulatero P; Milan A; Leotta G; Caserta M; Bertello C; Rabbia F; Veglio F
    J Hypertens; 2006 Dec; 24(12):2459-64. PubMed ID: 17082730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolongation of the QT interval in primary aldosteronism.
    Matsumura K; Fujii K; Kansui Y; Arima H; Iida M
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):66-9. PubMed ID: 15730437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QT interval is prolonged but QT dispersion is maintained in patients with primary aldosteronism.
    Yang TY; Cheng NJ; Ko YS; Kuo CT
    Int J Clin Pract; 2007 Mar; 61(3):392-6. PubMed ID: 16749916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuminuria in untreated patients with primary aldosteronism or essential hypertension.
    Halimi JM; Mimran A
    J Hypertens; 1995 Dec; 13(12 Pt 2):1801-2. PubMed ID: 8903655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin and insulin sensitivity in primary aldosteronism.
    Fallo F; Della Mea P; Sonino N; Bertello C; Ermani M; Vettor R; Veglio F; Mulatero P
    Am J Hypertens; 2007 Aug; 20(8):855-61. PubMed ID: 17679033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
    Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [QT interval dispersion in hypertensive diabetics and in patients with hypertension with chronic heart failure without diabetes].
    Radman A; Murín J; Bulas J; Reptová A; Ravingerová T; Mikes P; Kozliková K; Ghanem W; Jaber J; Baqi L
    Vnitr Lek; 2003 Oct; 49(10):802-7. PubMed ID: 14682153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
    Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
    Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aldosterone/plasma renin activity ratio is a sensitive parameter for screening patients with primary aldosteronism].
    Zhang HL; Liu ZJ; Shao JM; Yan JT; Wang DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):873-6. PubMed ID: 17217709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tp-e interval, Tp-e/QT and Tp-e/QTc ratio in hypertensive patients with primary aldosteronism.
    Demirtas D; Sumbul HE; Bulut A; Demirtas AO; Gulumsek E; Koca H; Icen YK; Koc M
    Clin Exp Hypertens; 2020; 42(1):93-98. PubMed ID: 31204516
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
    Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
    Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
    Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships of plasma renin levels with renal function in patients with primary aldosteronism.
    Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):722-31. PubMed ID: 17699488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
    Voiculescu M; Ionescu C; Ismail G
    Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged QT interval and reduced heart rate variability in patients with uncomplicated essential hypertension.
    Maule S; Rabbia F; Perni V; Tosello F; Bisbocci D; Mulatero P; Veglio F
    Hypertens Res; 2008 Nov; 31(11):2003-10. PubMed ID: 19098371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular repolarization before and after treatment in patients with secondary hypertension due to renal-artery stenosis and primary aldosteronism.
    Maule S; Bertello C; Rabbia F; Milan A; Mulatero P; Milazzo V; Papotti G; Veglio F
    Hypertens Res; 2011 Oct; 34(10):1078-81. PubMed ID: 21677661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range.
    Tomaschitz A; Maerz W; Pilz S; Ritz E; Scharnagl H; Renner W; Boehm BO; Fahrleitner-Pammer A; Weihrauch G; Dobnig H
    J Am Coll Cardiol; 2010 May; 55(19):2171-80. PubMed ID: 20447545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary hyperaldosteronism--12 clinical cases].
    Telles EC; Machado FS; da Silva EP; Lutucuta S; Almeida G; Coucelo J; Vagueiro C
    Rev Port Cardiol; 1999 Sep; 18(9):801-12. PubMed ID: 10536470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.
    Wu VC; Kuo CC; Chang HW; Tsai CT; Lin CY; Lin LY; Lin YH; Wang SM; Huang KH; Fang CC; Ho YL; Liu KL; Chang CC; Chueh SC; Lin SL; Yen RF; Wu KD;
    Clin Chim Acta; 2010 May; 411(9-10):657-63. PubMed ID: 20117105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.